Clinical Efficacy of Indomethacin in Early Treatment of Acute Pancreatitis
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University
Listed as NCT05637281, this NA trial focuses on Acute Pancreatitis and Systemic Inflammatory Response Syndrome and remains ongoing. Sponsored by Second Affiliated Hospital, School of Medicine, Zhejiang University, it has been updated 5 times since 2022, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Change History
5 versions recorded-
Dec 2024 — Present [monthly]
Unknown NA
Status: Recruiting → Unknown
-
Sep 2024 — Dec 2024 [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
-
Mar 2023 — Jul 2024 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Jan 2023 — Mar 2023 [monthly]
Not Yet Recruiting NA
First recorded
Dec 2022
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Second Affiliated Hospital, School of Medicine, Zhejiang University
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
- • Hangzhou, China